Latest Royalties News

Neuren’s partner Acadia secures positive CHMP opinion for DAYBU® in Rett syndrome, paving the way for first EU treatment approval and triggering significant milestone payments for Neuren.

TerraCom signals operational recovery with improved coal sales guidance and cost reductions at Blair Athol, while advancing leadership appointments and strategic reviews.

Platina Resources has secured full ownership of the Sunrise Bore Project near Laverton, WA, and kicked off a 2,775-metre drilling program targeting a historically mineralised gold corridor.

Pacific Nickel Mines continues mining at Kolosori under Glencore finance while progressing a conditional sale of its Solomon Islands assets to Green Rock Limited.

DGR Global is sharpening its focus on copper and gold exploration in Queensland and Ecuador while pursuing a potentially lucrative damages case linked to Armour Energy's liquidation. The company also plans a share buy-back to unlock shareholder value.

Mesoblast has drawn US$50 million from a new five-year facility that reduces its interest burden and retires expensive short-term debt, strengthening its financial position ahead of commercial expansion.

Vinyl Group has completed its acquisition of Time Out Australia, securing exclusive rights to the brand and expanding its media reach across digital and events platforms.

Charger Metals has expanded its Medcalf Lithium Inferred Mineral Resource Estimate by 34% to 10.6 million tonnes at 1.0% Li2O, with tantalum grades also impressively high. The adjacent Medcalf West target adds further upside as Charger refocuses on advancing Lake Johnston.

Turaco Gold has exercised an option to acquire 100% of a new exploration permit adjacent to its Afema Project in Côte d’Ivoire, increasing its landholding by 30% and setting the stage for fresh exploration activities.

Calix’s Leilac unit has teamed up with Ambuja Cements to trial a commercial-scale carbon capture retrofit at the Sanghi plant, aiming to slash emissions and fuel costs without upfront capital.

Recce Pharmaceuticals has secured ethics approval to upgrade and broaden its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, accelerating recruitment and reinforcing its global registration ambitions.

Austral Gold has confirmed significant silver-gold mineralisation across multiple veins at its Juncal Project in Chile, setting the stage for its first-ever drilling campaign.